Mijalski Christina, Silver Brian
Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Neurohospitalist. 2015 Jul;5(3):151-60. doi: 10.1177/1941874415580598.
Transient ischemic attack (TIA) has gained increasing attention over the last 2 decades with the realization that the condition is common, portends potentially serious consequences, and, when identified early, can be evaluated and treated to modify future risk. In this review, we examine the issues of whether all TIA patients need admission and whether such patients should receive short-term dual antiplatelet therapy. Not all patients require admission if evaluation and treatment are done promptly. There may be a role for dual antiplatelet therapy, but the results of further clinical trials will help provide better clarity on which patients are the best candidates for this treatment.
在过去20年里，短暂性脑缺血发作（TIA）日益受到关注，因为人们认识到这种疾病很常见，可能预示着潜在的严重后果，而且如果早期发现，可以进行评估和治疗以改变未来风险。在本综述中，我们探讨了所有TIA患者是否都需要住院以及此类患者是否应接受短期双重抗血小板治疗的问题。如果能迅速进行评估和治疗，并非所有患者都需要住院。双重抗血小板治疗可能有一定作用，但进一步临床试验的结果将有助于更清楚地确定哪些患者是这种治疗的最佳候选者。
